FDA Inspection 1270494 — Vitalant

Vitalant — FEI 1000123568

The FDA completed an inspection of Vitalant on Apr 25, 2025 in Auburn, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 25, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Auburn, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.